Paul Joseph Dyson, Aspasia Gkasti, Yameng Hao
Pleural mesothelioma is a fatal disease with limited treatment options. Recently, pleural mesothelioma management has improved with the development of immune checkpoint inhibitors (ICI). In first-line therapy, dual PD-1 and CTLA-4 blockade enhances tumor c ...
AMER ASSOC CANCER RESEARCH2025